Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-9,000
Closed -$1.71M 71
2019
Q1
$1.71M Buy
9,000
+420
+5% +$80.2K 0.64% 33
2018
Q4
$1.67M Buy
8,580
+1,880
+28% +$367K 0.83% 26
2018
Q3
$1.39M Hold
6,700
0.7% 23
2018
Q2
$1.24M Hold
6,700
0.39% 30
2018
Q1
$1.14M Buy
+6,700
New +$1.23M 0.35% 56

Other funds holding AMGN

Polianta Ltd's AMGN Position: Q2 2019 in Review

Polianta Ltd sold out of Amgen (AMGN) in Q2 2019, closing a stake of 9,000 shares — an estimated $1.71M sold.

Polianta Ltd first reported a position in AMGN in Q1 2018 and held it in 5 quarters. The position peaked at $1.71M in Q1 2019. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

  • Polianta Ltd reported no remaining Amgen position as of Q2 2019 after selling out during the quarter.
  • Polianta Ltd sold 9,000 Amgen shares in Q2 2019, an estimated $1.71M.
  • Polianta Ltd first reported a position in Amgen in Q1 2018 and held it in 5 quarters.
  • Polianta Ltd's Amgen position peaked at $1.71M in Q1 2019.
  • 1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Polianta Ltd's 13F filing for Q2 2019, filed 17 Jul 2019.